EBRD exits Ibnsina Pharma
The EBRD acquired a 20% stake in the pharma player back in 2015
Available in your choice of English or Arabic
The EBRD acquired a 20% stake in the pharma player back in 2015
Pharma prices are expected to remain stable throughout the year
A new schedule to settle the accumulated USD 6.5 bn in arrears had been agreed with companies
The start of production will see Egypt become a net exporter of insulin glargine
The revamp would keep the company’s assets, while developing production lines and capacity
Cairo Metro Line 6 will link Shubra El Kheima in the north to New Maadi in the south
The first phase of the project is set to begin operating in mid-2025
The pharma sector is set to implement phased price hikes affecting around 100 drugs per month
Something went wrong. Please refresh the page and/or try again.
Queue